The prognostic outcome of acute myelogenous leukemia (AML) patients with a history of myelodysplastic syndrome is significantly worse than those without prior MDS. It is thought that approximately 40% of AML multilineage dysplasia (MLD) patients have a history of MDS. In this study a pool of AML-MLD patients were retrospectively investigated for primary MDS.
This research was supported by the Undergraduate Research Opportunities Program (UROP).
Evaluating Primary Myelodysplastic Syndrome in Acute Myeloid Leukemia Patients.
Retrieved from the University of Minnesota Digital Conservancy,
Content distributed via the University of Minnesota's Digital Conservancy may be subject to additional license and use restrictions applied by the depositor.